MindsAI is a comprehensive mental healthcare solutions provider. We offer two KFDA-approved products designed to diagnose depression using salivary biomarkers and treat the condition through VR-augmented Cognitive Behavioral Therapy (CBT).

 

Aligned with the World Health Organization’s mission, we believe that depression is treatable and suicide is preventable.

 

Furthermore, MindsAI is actively developing further treatments for panic disorder, social anxiety, PTSD, and dementia. MindsAI is committed to becoming a global leader in mental healthcare innovation.

 

MindsAI will be the most optimal partner for the companies who care about their employee's mental health.

​

Website - https://mindsai.co.kr/